Showing 5,885 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Injectable & long-acting HIV treatment

New Guideline for Replacement ART: CAB/RPV LA Not for Everyone

Editor's pick
Medscape (requires free registration)
3 August 2021
Injectable & long-acting HIV treatment

A Change of Pace

Editor's pick
POZ
2 August 2021
Access to healthcare

Pricing agreement brings HIV drug darunavir within reach of LMICs

Editor's pick
Devex
29 July 2021
Antibody-based prevention

HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher

News
28 July 2021
Injectable & long-acting HIV treatment

Failed viral suppression in CAB/RPV linked to 3 Risk Factors

Editor's pick
Medscape (requires free registration)
28 July 2021
Access to healthcare

Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries

Editor's pick
Clinton Health Access Initiative
28 July 2021
Support issues for children & young people

Uganda: Trial finds improving household finances linked to effective HIV treatment

Editor's pick
Avert
24 July 2021
The search for a cure

Novel dual antibody therapy partially controls virulent HIV infection in monkeys off treatment

News
23 July 2021
Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
The search for a cure

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir

News
21 July 2021
New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021
PrEP science

PrEP failures in African programmes are rare, but some are happening in people with good adherence

News
21 July 2021
Viral load

Viral suppression in Uganda improved by more viral load tests, done faster

News
20 July 2021
Delivery of care

Long-acting injectable HIV treatment is feasible, even during COVID-19

News
20 July 2021
Injectable & long-acting HIV treatment

Twice-a-year injected drug shows promise for first-line HIV treatment

News
19 July 2021
HIV treatment for children & young people

Adolescent-centred interventions lead to a 30-percentage-point increase in viral suppression in Namibia, and a 20-percentage-point increase in Nigeria

News
19 July 2021
Retention & linkage to care

Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment

News
18 July 2021
Treatment guidelines

Most countries with the greatest burden of HIV still don’t recommend dolutegravir for all

News
18 July 2021
Treatment guidelines

WHO publishes new Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring

Editor's pick
World Health Organization
17 July 2021
New & experimental HIV treatments

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy

News
17 July 2021
HIV treatment

Efavirenz/emtricitabine/tenofovir disoproxil fumarate Factsheet

About HIV
July 2021
Treatment outcomes & life expectancy

Americans Living With HIV Have Near-Normal Life Expectancy: Study

Editor's pick
HealthDay News
8 July 2021
HIV treatment

Efavirenz/emtricitabine/tenofovir disoproxil fumarate Detailed information

About HIV
July 2021
Ageing & HIV

Yvonne Richards on ageing with HIV – GROWS project Video

About HIV
July 2021